| Original language | English |
|---|---|
| Title of host publication | Comprehensive Nanoscience and Nanotechnology |
| Publisher | Elsevier |
| Chapter | 3.11 |
| Pages | 211-226 |
| Number of pages | 16 |
| Volume | 3 |
| Edition | 2 |
| ISBN (Electronic) | 9780128122952 |
| ISBN (Print) | 9780128122969 |
| DOIs | |
| Publication status | Published - 1 Jan 2019 |
Abstract
Drug delivery using nanosized materials holds significant potential to resolve challenges faced by conventional enteral and parental therapeutic administration, including poor drug solubility and off-target toxic effects. Porous silicon (pSi) nanostructures possess large surface areas in relation to volume and exhibit high biocompatibility. Tunable pore size and versatile surface functionalisation allows carriers to be created to match drug characteristics, maximising loading capacity. This chapter reviews the fabrication of pSi nanoparticles and their use for targeted drug delivery. Particular emphasis is placed on surface functionalisation regimes typically employed to construct biocompatible nanoparticles. The qualification of candidate pSi nanoparticles as biocompatible and fit-for-purpose, required for progression to therapeutic use, are discussed. We particularly focus on the application of pSi nanocarriers for cancer therapies and chronic wound healing.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anti-infectives
- Biocompatibility
- Cancer therapy
- Drug delivery
- Gene delivery
- Nano-medicine
- Nanoparticles
- Nitrous oxide
- Porous silicon
- siRNA
- Surface functionalization
Equipment
-
Melbourne Centre for Nanofabrication (MCN)
Langelier, S. (Manager)
Office of the Vice-Provost (Research and Research Infrastructure)Facility/equipment: Facility
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver